A novel IRAK4/PIM1 inhibitor ameliorates rheumatoid arthritis and lymphoid malignancy by blocking the TLR/MYD88-mediated NF- κ B pathway
新型 IRAK4/PIM1 抑制剂通过阻断 TLR/MYD88 介导的 NF- κ B 通路改善类风湿关节炎和淋巴恶性肿瘤
期刊:Acta Pharmaceutica Sinica B
影响因子:14.7
doi:10.1016/j.apsb.2022.12.001
Sae-Bom Yoon, Hyowon Hong, Hee-Jong Lim, Ji Hye Choi, Yoon Pyo Choi, Seong Wook Seo, Hyuk Woo Lee, Chong Hak Chae, Woo-Kyu Park, Hyun Young Kim, Daeyoung Jeong, Tran Quang De, Chang-Seon Myung, Heeyeong Cho